论文部分内容阅读
子宫平滑肌肉瘤占子宫恶性肿瘤的1％,占子宫肉瘤25％,被认为是一种高度恶性的肿瘤,生存率为0％～73％,差异主要是因为以前对子宫平滑肌肉瘤的诊断欠精确和诊断标准的不统一。为评价子宫平滑肌肉瘤的生物学行为与其临床病理特征及影响预后因素之间的关系,对1973～1995年在Vienna、Graz及Innsbruck三家医院妇产科接受治疗的71例病人,按FIGO子宫内膜癌的分期标准进行分期(但未区分I_A和I_B期)。所有切片由病理学专家进行复核,以每10个高倍视野出现≥5个核分裂相和核异形作为诊断标准。手术均采用全子宫加双附件切除,有盆腔、腹腔播散者尽可能切除瘤体病灶,
Uterine leiomyosarcoma accounted for 1% of uterine malignancies, accounting for 25% of uterine sarcomas, is considered to be a highly malignant tumor, the survival rate was 0% to 73%, the difference is mainly due to the previous diagnosis of uterine leiomyosarcoma less accurate and Diagnostic criteria are not uniform. To evaluate the relationship between the biological behavior of uterine leiomyosarcoma and its clinicopathological features and prognostic factors, 71 patients with gynecological and obstetric treatment in the three hospitals of Vienna, Graz and Innsbruck from 1973 to 1995 were selected according to FIGO endometrium Stages of cancer were staged (but I_A and I_B were indistinguishable). All sections were reviewed by pathologists, with ≥ 5 mitotic and nuclear abnormalities at 10 high power fields as diagnostic criteria. Surgery were used both uterine and double attachment resection, a pelvic, abdominal disseminated removal of tumor lesions as much as possible,